论文部分内容阅读
遗传性QT间期延长综合征的药物治疗已取得了显著疗效 ,近年来分子遗传学技术研究的突破性进展 ,为以基因型为基础的药物治疗提供了新思路 ,并已展示出可喜苗头。
Hereditary QT prolongation syndrome drug therapy has achieved remarkable results. In recent years, breakthroughs in molecular genetics technology research provide a new idea for genotype-based drug treatment and have shown gratifying signs.